# Roper Technologies Inc: Form 10-Q for the period ended Mar 31, 2021

- Company: [Roper Technologies Inc](/companies/rop.md) (CIK 882835)
- Form: 10-Q
- Filed: 2021-05-05
- Accepted by EDGAR: May 5, 2021, 09:15 ET
- Period: 2021-03-31
- Accession: 0000882835-21-000018
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/882835/000088283521000018/rop-20210331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882835/000088283521000018/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-01-01 to 2021-03-31 | $1.53bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-01-01 to 2021-03-31 | $534.8m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2021-01-01 to 2021-03-31 | $993.8m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2021-01-01 to 2021-03-31 | $593.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-01-01 to 2021-03-31 | $400.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-01-01 to 2021-03-31 | $60.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-01-01 to 2021-03-31 | $77.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-01-01 to 2021-03-31 | $289.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-01-01 to 2021-03-31 | $2.73 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-01-01 to 2021-03-31 | $2.75 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-01-01 to 2021-03-31 | 106,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2021-01-01 to 2021-03-31 | $559.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 3 months, 2021-01-01 to 2021-03-31 | $58.8m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | at 2021-03-31 | $331.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-03-31 | $1.74bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-03-31 | $23.87bn | us-gaap:Assets |
| Current liabilities | at 2021-03-31 | $2.46bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-03-31 | $13.11bn | us-gaap:Liabilities |
| Long-term debt | at 2021-03-31 | $8.57bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-03-31 | $502.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2021-03-31 | $10.77bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 24,698 characters.

You should read the following discussion in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2020 (“Annual Report”) as filed on February 22, 2021 with the U.S. Securities and Exchange Commission (“SEC”) and the Notes to Condensed Consolidated Financial Statements included elsewhere in this report.

### Information About Forward-Looking Statements

This report includes “forward-looking statements” within the meaning of the federal securities laws. In addition, we, or our executive officers on our behalf, may from time to time make forward-looking statements in reports and other documents we file with the U.S. Securities and Exchange Commission (“SEC”) or in connection with oral statements made to the press, potential investors or others. All statements that are not historical facts are “forward-looking statements.” Forward-looking statements may be indicated by words or phrases such as “anticipate,” “estimate,” “plans,” “expects,” “projects,” “should,” “will,” “believes” or “intends” and similar words and phrases. These statements reflect management’s current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in any forward-looking statement. Such risks and uncertainties include the effects of the COVID-19 pandemic on our business, operations, financial results and liquidity, including the duration and magnitude of such effects, which will depend on numerous evolving factors that we cannot accurately predict or assess, including: the duration and scope of the pandemic generally and in the geographical markets that we serve or in which we operate; the negative impact on global and regional markets, economies and economic activity; actions governments, businesses and individuals take in response to the pandemic; the effects of the pandemic, including all of the foregoing, on our employees, customers, suppliers, and business partners, and how quickly economies and demand for our products and services recover following the pandemic.

Additional examples of forward-looking statements in this report include but are not limited to statements regarding operating results, the success of our operating plans, our expectations regarding our ability to generate cash and reduce debt and associated interest expense, profit and cash flow expectations, the prospects for newly acquired businesses to be integrated and contribute to future growth and our expectations regarding growth through acquisitions. Important assumptions relating to the forward-looking statements include, among others, demand for our products, the cost, timing and success of product upgrades and new product introductions, raw material costs, expected pricing levels, expected outcomes of pending litigation, competitive conditions and general economic conditions. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the forward-looking statements are reasonable, our expectations may prove to be incorrect. Important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to:

- general economic conditions;
- difficulty making acquisitions and successfully integrating acquired businesses;
- any unforeseen liabilities associated with future acquisitions;
- limitations on our business imposed by our indebtedness;
- unfavorable changes in foreign exchange rates;
- failure to effectively mitigate cybersecurity threats, including any litigation arising therefrom;
- failure to comply with new data privacy laws and regulations, including any litigation arising therefrom;
- difficulties associated with exports/imports and risks of changes to tariff rates;
- risks and costs associated with our international sales and operations;
- rising interest rates;
- product liability and insurance risks;
- increased warranty exposure;
- future competition;
- the cyclical nature of some of our markets;
- reduction of business with large customers;
- risks associated with government contracts;
- changes in the supply of, or price for, raw materials, parts and components;
- environmental compliance costs and liabilities;
- risks and costs associated with asbestos-related litigation;
- potential write-offs of our goodwill and other intangible assets;
- our ability to successfully develop new products;
- failure to protect our intellectual property;
- the effect of, or change in, government regulations (including tax);
- economic disruption caused by terrorist attacks, health crises (such as the COVID-19 pandemic) or other unforeseen geopolitical events; and
- the factors discussed in other reports filed with the SEC from time to time.

We believe these forward-looking statements are reasonable. However, you should not place undue reliance on any forward-looking statements, which are based on current expectations. Further, forward-looking statements speak only as of the date they are made, and we undertake no obligation to publicly update any of them in light of new information or future events.

### Overview

Roper Technologies, Inc. (“Roper,” “we,” “us” or “our”) is a diversified technology company. We operate businesses that design and develop software (both license and SaaS) and engineered products and solutions for a variety of niche end markets.

We pursue consistent and sustainable growth in earnings and cash flow by emphasizing continuous improvement in the operating performance of our existing businesses and by acquiring other businesses that offer high value-added software, services, engineered products and solutions that we believe are capable of achieving growth and maintaining high margins. We compete in many niche markets and believe we are the market leader or a competitive alternative to the market leader in most of these markets.

### Critical Accounting Policies

There were no material changes during the three months ended March 31, 2021 to the items that we disclosed as our critical accounting policies and estimates in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report.

### Recently Issued Accounting Standards

Information regarding new accounting pronouncements is included in Note 2 of the Notes to Condensed Consolidated Financial Statements.

### Impact of COVID-19 on our Business

Our top priority during the coronavirus (COVID-19) pandemic is the health and safety of our employees, customers and vendors. The leadership teams at our businesses continue to be proactive in instituting safety measures that protect our employees, customers and vendors, while maintaining operational capabilities required to meet our customers’ needs. All our businesses with manufacturing facilities have been deemed essential businesses and remain operational, supplying our customers with critical products. Additionally, all of our businesses continue to be operational in their work-from-home environments with limited disruption.

The spread of COVID-19 has caused us to modify our business practices, and we may take further actions as required by governmental and other regulatory authorities or as we determine to protect the safety or best interests of our employees, customers, suppliers and business partners. Some changes in business practices include, but are not limited to: restricting employee travel, developing social distancing plans for our employees, expanding the number of our associates who work from home, and cancelling physical participation in meetings, events and conferences.

The extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on future developments, which are highly uncertain and are difficult to predict, including, but not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus and its variants including distribution and administration of available vaccines, and how quickly and to what extent normal economic and operating conditions can resume. As COVID-19 and its variants spread, particularly in countries with low vaccination rates, certain countries may experience more severe and lasting impacts from the pandemic. To the extent we have operations and/or customers in these countries, we may experience adverse impacts on our businesses located in such countries. For example, India is currently experiencing a severe outbreak of COVID-19. While most of our employees located in India are currently able to continue to operate in work-from-home environments, to the extent the outbreak intensifies or persists indefinitely it is difficult to predict how such outbreak may ultimately impact our businesses with employees and/or operations located in India.

### Results of Operations

### All currency amounts are in millions, percentages are of net revenues

General

Percentages may not sum due to rounding.

The following table sets forth selected information for the periods indicated.

| Net revenues: | Three months ended March 31, 2021 | 2020 |
| --- | ---: | ---: |
| Application Software | $576.6 | $405.1 |
| Network Software & Systems | 440.2 | 438.2 |
| Measurement & Analytical Solutions | 381.0 | 365.2 |
| Process Technologies | 130.8 | 142.2 |
| Total | $1,528.6 | $1,350.7 |
| Gross margin: |  |  |
| Application Software | 69.1% | 66.7% |
| Network Software & Systems | 68.0 | 66.9 |
| Measurement & Analytical Solutions | 59.0 | 58.8 |
| Process Technologies | 54.3 | 55.3 |
| Total | 65.0 | 63.4 |
| Selling, general and administrative expenses: |  |  |
| Application Software | 42.5% | 42.7% |
| Network Software & Systems | 37.2 | 35.3 |
| Measurement & Analytical Solutions | 26.4 | 27.5 |
| Process Technologies | 25.0 | 24.8 |
| Total | 35.5 | 34.3 |
| Segment operating margin: |  |  |
| Application Software | 26.7% | 24.1% |
| Network Software & Systems | 30.8 | 31.7 |
| Measurement & Analytical Solutions | 32.6 | 31.2 |
| Process Technologies | 29.3 | 30.5 |
| Total | 29.5 | 29.1 |
| Corporate administrative expenses | (3.3) | (3.3) |
| Income from operations | 26.2 | 25.9 |
| Interest expense, net | (4.0) | (3.4) |
| Other income (expense), net | 1.8 | 0.1 |
| Earnings before income taxes | 24.0 | 22.6 |
| Income taxes | (5.1) | (4.8) |
| Net earnings | 18.9% | 17.8% |

### Three months ended March 31, 2021 compared to three months ended March 31, 2020

Net revenues for the three months ended March 31, 2021 increased by 13% as compared to the three months ended March 31, 2020. The increase was the result of net acquisition/divestiture contribution of 12% and a foreign exchange benefit of 1%, partially offset by an organic decline of 1%.

In our Application Software segment, revenues were $576.6 in the first quarter of 2021 as compared to $405.1 in the first quarter of 2020, an increase of 42%. Acquisitions contributed 38%, organic revenues increased 2% and foreign exchange contributed 1% to growth in the segment. The increase in organic revenues was due primarily to our businesses serving the healthcare and government contracting markets, partially offset by declines in our businesses serving the education markets. Gross margin increased to 69.1% in the first quarter of 2021 as compared to 66.7% in the first quarter of 2020 due primarily to the acquisition of Vertafore and favorable revenue mix across the segment. Selling, general and administrative (“SG&A”) expenses as a percentage of revenues decreased to 42.5% in the first quarter of 2021 as compared to 42.7% in the first quarter of 2020 due primarily to operating leverage on organic revenue growth, partially offset by higher amortization of acquired intangibles from the Vertafore and EPSi acquisitions. The resulting operating margin was 26.7% in the first quarter of 2021 as compared to 24.1% in the first quarter of 2020.

In our Network Software & Systems segment, revenues were relatively flat at $440.2 in the first quarter of 2021 as compared to $438.2 in the first quarter of 2020. Organic revenues decreased 2%, offset by growth in the segment due to contributions from acquisitions of 2% and foreign exchange of 1%. The decrease in organic revenues was primarily due to project timing and lower toll tag volumes in our toll and traffic business, partially offset by subscription growth at our SaaS businesses. Gross margin increased to 68.0% in the first quarter of 2021 as compared to 66.9% in the first quarter of 2020 due primarily to revenue mix. SG&A expenses as a percentage of revenues increased to 37.2% in the first quarter of 2021 as compared to 35.3% in the first quarter of 2020 due primarily to revenue mix. As a result, operating margin was 30.8% in the first quarter of 2021 as compared to 31.7% in the first quarter of 2020.

Our Measurement & Analytical Solutions segment revenues increased by 4% to $381.0 in the first quarter of 2021 as compared to $365.2 in the first quarter of 2020. Organic revenues increased 2% and foreign exchange contributed 2% to growth in the segment. The growth in organic revenues was primarily due to our medical products businesses, partially offset by declines in our water meter technology business, due to restricted access to indoor meters located in the Northeast United States and Canada. Gross margin increased to 59.0% in the first quarter of 2021 as compared to 58.8% in the first quarter of 2020 due primarily to revenue mix. SG&A expenses as a percentage of revenues decreased to 26.4% in the first quarter of 2021 as compared to 27.5% in the first quarter of 2020 due primarily to higher operating leverage on organic revenue growth. The resulting operating margin was 32.6% in the first quarter of 2021 as compared to 31.2% in the first quarter of 2020.

Our Process Technologies segment revenues decreased by 8% to $130.8 in the first quarter of 2021 as compared to $142.2 in the first quarter of 2020. Organic revenues decreased 10%, partially offset by a foreign exchange contribution of 2%. Organic revenues decreased due to broad-based revenue declines across the segment led by lower demand at our businesses serving upstream oil and gas end markets. Gross margin decreased to 54.3% in the first quarter of 2021 as compared to 55.3% in the first quarter of 2020 due primarily to lower revenues across the businesses. SG&A expenses as a percentage of revenues increased to 25.0% in the first quarter of 2021 as compared to 24.8% in the first quarter of 2020 due primarily to lower operating leverage on organic revenue declines. As a result, operating margin was 29.3% in the first quarter of 2021 as compared to 30.5% in the first quarter of 2020.

Corporate expenses increased to $51.1, or 3.3% of revenues, in the first quarter of 2021 as compared to $44.4, or 3.3% of revenues, in the first quarter of 2020. The dollar increase was due primarily to higher compensation related expenses, partially offset by lower acquisition related expenses.

Net interest expense was $60.6 for the first quarter of 2021 as compared to $45.4 for the first quarter of 2020 due to higher weighted average debt balances, partially offset by lower weighted average interest rates.

Other income, net, of $27.0 for the first quarter of 2021 was composed primarily of a gain on sale of minority investment of $27.1. Other income, net, of $0.8 for the first quarter of 2020 was composed primarily of foreign exchange gains at our non-U.S. based subsidiaries

Income taxes as a percent of pretax earnings were relatively flat at 21.2% in the first quarter of 2021 as compared to 21.1% in the first quarter of 2020.

Backlog is equal to our remaining performance obligations expected to be recognized within the next 12 months as discussed in Note 10 of the Notes to Condensed Consolidated Financial Statements. Backlog increased 25% to $2,578.7 at March 31, 2021 as compared to $2,070.3 at March 31, 2020, organic growth was 3% and acquisitions contributed 22%.

|  | Backlog as of March 31, 2021 | 2020 |
| --- | ---: | ---: |
| Application Software | $1,394.6 | $838.6 |
| Network Software & Systems | 814.4 | 877.9 |
| Measurement & Analytical Solutions | 252.8 | 236.3 |
| Process Technologies | 116.9 | 117.5 |
| Total | $2,578.7 | $2,070.3 |

### Financial Condition, Liquidity and Capital Resources

### All currency amounts are in millions

Selected cash flows for the three months ended March 31, 2021 and 2020 were as follows:

| Cash provided by/(used in): | Three months ended March 31, 2021 | 2020 |
| --- | ---: | ---: |
| Operating activities | $559.6 | $363.9 |
| Investing activities | 10.7 | (17.0) |
| Financing activities | (545.2) | (38.7) |

Operating activities - Net cash provided by operating activities increased by 54% to $559.6 in the three months ended March 31, 2021 as compared to $363.9 in the three months ended March 31, 2020, due primarily to higher net income net of non-cash expenses and growth in our software businesses, which generated cash from working capital in the quarter. Additionally, wins at our UK-based laboratory software business generated approximately $36 of accelerated cash payments in the quarter.

Investing activities - Cash provided by investing activities during the three months ended March 31, 2021 is due primarily to the proceeds from the sale of a minority investment, partially offset by capital expenditures. Cash used in investing activities during the three months ended March 31, 2020 was primarily for capital expenditures.

Financing activities - Cash used in financing activities for the three months ended March 31, 2021 was primarily due to net repayments on our unsecured credit facility and dividend payments. Cash used in financing activities during the three months ended March 31, 2020 was primarily due to dividend payments, partially offset by net proceeds from stock-based compensation.

Effect of foreign currency exchange rate changes on cash - Cash and cash equivalents decreased during the three months ended March 31, 2021 by $2.4 due primarily to the strengthening of the U.S. dollar against the functional currencies of our European subsidiaries. Cash and cash equivalents decreased during the three months ended March 31, 2020 by $18.1 due primarily to the strengthening of the U.S. dollar against the functional currencies of our United Kingdom, European and Canadian subsidiaries.

Total debt at March 31, 2021 consisted of the following:

|  |  |
| --- | ---: |
| $500 2.800% senior notes due 2021 | 500.0 |
| $500 3.125% senior notes due 2022 | 500.0 |
| $300 0.450% senior notes due 2022 | 300.0 |
| $700 3.650% senior notes due 2023 | 700.0 |
| $500 2.350% senior notes due 2024 | 500.0 |
| $300 3.850% senior notes due 2025 | 300.0 |
| $700 1.000% senior notes due 2025 | 700.0 |
| $700 3.800% senior notes due 2026 | 700.0 |
| $700 1.400% senior notes due 2027 | 700.0 |
| $800 4.200% senior notes due 2028 | 800.0 |
| $700 2.950% senior notes due 2029 | 700.0 |
| $600 2.000% senior notes due 2030 | 600.0 |
| $1,000 1.750% senior notes due 2031 | 1,000.0 |
| Unsecured credit facility | 1,125.0 |
| Deferred finance costs | (56.8) |
| Other | 5.7 |
| Total debt, net of deferred finance costs | 9,073.9 |
| Less current portion | 502.1 |
| Long-term debt, net of deferred finance costs | $8,571.8 |

The interest rate on borrowings under our $3,000.0 unsecured credit facility is calculated based upon various recognized indices plus a margin as defined in the credit facility. At March 31, 2021, there were $1,125.0 outstanding borrowings under our unsecured credit facility. At March 31, 2021, we had $5.7 of other debt in the form of short term borrowings, finance leases and several smaller facilities that allow for borrowings in various foreign locations to support our non-U.S. businesses and $67.1 of outstanding letters of credit.

Cash at our foreign subsidiaries at March 31, 2021 increased to $296 as compared to $259 at December 31, 2020 due primarily to the cash generated at our foreign subsidiaries during the three months ended March 31, 2021, partially offset by the repatriation of $107 during the quarter. We intend to repatriate substantially all historical and future earnings.

We expect existing cash balances, together with cash generated by our operations and amounts available under our credit facility, will be sufficient to fund our operating requirements for the foreseeable future.

We were in compliance with all debt covenants related to our unsecured credit facility throughout the three months ended March 31, 2021.

Net working capital (total current assets, excluding cash, less total current liabilities, excluding debt) was negative $552.4 at March 31, 2021 as compared to negative $498.4 at December 31, 2020, reflecting a decrease in working capital due primarily to a decrease in accounts receivable, net and an increase in income taxes payable, partially offset by a decrease in accrued compensation resulting from the timing of payments. Consistent negative net working capital demonstrates Roper’s continued evolution and focus on asset-light business models. Total debt was $9,073.9 at March 31, 2021 as compared to $9,566.5 at December 31, 2020, due primarily to the net repayments under our unsecured credit facility. Our leverage is shown in the following table:

|  | March 31, 2021 | December 31, 2020 |
| --- | ---: | ---: |
| Total debt | $9,073.9 | $9,566.5 |
| Cash | (331.0) | (308.3) |
| Net debt | 8,742.9 | 9,258.2 |
| Stockholders’ equity | 10,765.7 | 10,479.8 |
| Total net capital | $19,508.6 | $19,738.0 |
| Net debt / total net capital | 44.8% | 46.9% |

Capital expenditures were $9.1 for the three months ended March 31, 2021 as compared to $7.9 for the three months ended March 31, 2020. Capitalized software expenditures were $7.2 for the three months ended March 31, 2021 as compared to $2.6 for the three months ended March 31, 2020. We expect the aggregate of capital expenditures and capitalized software expenditures for the balance of the year to be comparable to prior years as a percentage of revenues.

### Off-Balance Sheet Arrangements

At March 31, 2021, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

### Outlook

Current geopolitical and economic uncertainties could adversely affect our business prospects. The COVID-19 pandemic has had, and may continue to have, an adverse impact on our business. A significant terrorist attack, other global conflict, or public health crisis could cause changes in world economies that would adversely affect us. It is impossible to isolate each of these potential factor’s future effects on current economic conditions or any of our businesses. It is also impossible to predict with any reasonable degree of certainty what or when any additional events may occur that also would similarly disrupt the economy and have an adverse impact on our businesses.

Although we maintain an active acquisition program we are currently focused on reducing debt. Future acquisitions will be dependent on numerous factors and it is not feasible to reasonably estimate if or when any such acquisitions will occur and what the impact will be on our business, financial condition and results of operations. Such acquisitions may be financed by the use of existing credit lines, future cash flows from operations, future divestitures, the proceeds from the issuance of new debt or equity securities or any combination of these methods, the terms and availability of which will be subject to market and economic conditions generally.

We anticipate that our businesses will generate positive cash flows from operating activities, and that these cash flows will permit the reduction of currently outstanding debt in accordance with the repayment schedule. However, the rate at which we can reduce our debt during 2021 (and reduce the associated interest expense) will be affected by, among other things, the financing and operating requirements of any new acquisitions, the financial performance of our existing companies and the impact of the COVID-19 pandemic on our business prospects and the financial markets generally. None of these factors can be predicted with certainty.

## Market risk

As filed, 172 characters.

See “Item 7A. Quantitative and Qualitative Disclosures about Market Risk” in our Annual Report. There were no material changes during the three months ended March 31, 2021.

## Controls and procedures

As filed, 1,556 characters.

As required by SEC rules, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q (“Evaluation Date”). This evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer. Based on this evaluation as of the Evaluation Date, these officers have concluded that the design and operation of our disclosure controls and procedures are effective.

Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes to our internal controls during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

## Risk factors

As filed, 437 characters.

Information regarding risk factors can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Information About Forward-Looking Statements,” in Part 1 - Item 2 of this Form 10-Q and in Part 1 - Item 1A of our 2020 Annual Report on Form 10-K. There were no material changes during the quarter ended March 31, 2021 to the risk factors reported in the Company’s 2020 Annual Report on Form 10-K.

Filed May 5, 2021.
Source: SEC EDGAR, the filing index for accession 0000882835-21-000018. Last ingested by Listed: Nov 14, 2026, 18:28 ET. No prices; not investment advice.
